Hepatitis B Patients Can Recover

The results of the latest international research on hepatitis B patients who undergo therapy with PEG Interferon Alfa 2-a (40D), not found again-s antigen or may be called clinically cured.

"The results of this study a new breakthrough is important because it affects a large reduction in the risk of liver cancer, cirrhosis, and increased life expectancy," says heart expert, Prof.Laurentinus Lesmana, in a discussion in Jakarta on Saturday (30 / 5).

Prof. Laurentinus says, hepatitis B is a health issue that is very worrying. The latest data showed more than 350 million people worldwide infected with the virus and one million people die every year and is one of the ten largest cause of death.

"Until the past few days, clinical cure in the treatment of hepatitis B is still considered unlikely. But the world's experts to make new breakthroughs and prove achieved clinical cure," he said.

Another heart expert, Dr Poernomo, said the preliminary findings will be confirmed again by the international study of hepatitis B that involved 24 countries and one of Indonesia. "In Indonesia will be involved 50 patients from three cities of Jakarta, Surabaya, and Bandung for a year," he said.

During this hepatitis drugs available, said Dr. Poernomo, do not kill the hepatitis virus because the virus completely from the old into the nucleus of cells in the liver and then continue to grow.

"Because it was found drugs how to make the immune system appears in the body so that the virus is completely destroyed," he said.